Skip to main content
. 2021 Oct 8;23(Suppl E):E184–E188. doi: 10.1093/eurheartj/suab118

Figure 2.

Figure 2

Mechanism of VIPIT. Vaccines against SAR-CoV-2 promote the formation of anti-PF4/polyanionic antibodies, which may activate platelets through the Fcγ-receptor IIA (FcγRIIA).